These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 29119954)

  • 1. [The role of dosed walking in the combination with elements of cognitive training in the comprehensive treatment of the patients presenting with Alzheimer's disease].
    Zimushkina NA; Kosareva PV; Cherkasova VG
    Vopr Kurortol Fizioter Lech Fiz Kult; 2017; 94(4):10-13. PubMed ID: 29119954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of combine treatment of memantine and donepezil on Alzheimer's disease patients and its relationship with cerebral blood flow in the prefrontal area.
    Araki T; Wake R; Miyaoka T; Kawakami K; Nagahama M; Furuya M; Limoa E; Liaury K; Hashioka S; Murotani K; Horiguchi J
    Int J Geriatr Psychiatry; 2014 Sep; 29(9):881-9. PubMed ID: 24436135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective study on the benefits of combined Memantine and cholinEsterase inhibitor treatMent in AGEd Patients affected with Alzheimer's Disease: the MEMAGE study.
    Gareri P; Putignano D; Castagna A; Cotroneo AM; De Palo G; Fabbo A; Forgione L; Giacummo A; Lacava R; Marino S; Simone M; Zurlo A; Putignano S
    J Alzheimers Dis; 2014; 41(2):633-40. PubMed ID: 24643135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clock drawing and frontal lobe behavioral effects of memantine in Alzheimer's disease: a rater-blinded study.
    Paskavitz JF; Gunstad JJ; Samuel JE
    Am J Alzheimers Dis Other Demen; 2006 Dec-2007 Jan; 21(6):454-9. PubMed ID: 17267379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Clock Drawing Test for dementia of the Alzheimer's type: A comparison of three scoring methods in a memory disorders clinic.
    Brodaty H; Moore CM
    Int J Geriatr Psychiatry; 1997 Jun; 12(6):619-27. PubMed ID: 9215942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive and affective benefits of combination therapy with galantamine plus cognitive rehabilitation for Alzheimer's disease.
    Tokuchi R; Hishikawa N; Matsuzono K; Takao Y; Wakutani Y; Sato K; Kono S; Ohta Y; Deguchi K; Yamashita T; Abe K
    Geriatr Gerontol Int; 2016 Apr; 16(4):440-5. PubMed ID: 25952367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effectiveness of reality orientation in the treatment of Alzheimer's disease.
    Camargo CH; Justus FF; Retzlaff G
    Am J Alzheimers Dis Other Demen; 2015 Aug; 30(5):527-32. PubMed ID: 25588408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects on agitation with rivastigmine patch monotherapy and combination therapy with memantine in mild to moderate Alzheimer's disease: a multicenter 24-week prospective randomized open-label study (the Korean EXelon Patch and combination with mEmantine Comparative Trial study).
    Yoon SJ; Choi SH; Na HR; Park KW; Kim EJ; Han HJ; Lee JH; Shim YS; Na DL
    Geriatr Gerontol Int; 2017 Mar; 17(3):494-499. PubMed ID: 27111084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repetitive transcranial magnetic stimulation combined with cognitive training for the treatment of Alzheimer's disease.
    Nguyen JP; Suarez A; Kemoun G; Meignier M; Le Saout E; Damier P; Nizard J; Lefaucheur JP
    Neurophysiol Clin; 2017 Feb; 47(1):47-53. PubMed ID: 28161090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does executive impairment define a frontal variant of Alzheimer's disease?
    Woodward M; Brodaty H; Boundy K; Ames D; Blanch G; Balshaw R;
    Int Psychogeriatr; 2010 Dec; 22(8):1280-90. PubMed ID: 20719041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Memantine (akatinol) therapy of cognitive impairment in Parkinson's disease complicated by dementia].
    Litvinenko IV; Odinak MM; Mogil'naia VI; Perstenev SV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(10):37-42. PubMed ID: 19008850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined application of tenuigenin and β-asarone improved the efficacy of memantine in treating moderate-to-severe Alzheimer's disease.
    Chang W; Teng J
    Drug Des Devel Ther; 2018; 12():455-462. PubMed ID: 29551889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An investigation of the efficiency of the mini-Kingston standardized cognitive assessment-revised in classifying patients according to DSM-5 major and mild neurocognitive disorders due to possible Alzheimer's disease.
    Heinik J; Kavé G
    Int Psychogeriatr; 2015 May; 27(5):785-91. PubMed ID: 25597552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive stimulation therapy for Alzheimer's disease: the effect of cognitive stimulation therapy on the progression of mild Alzheimer's disease in patients treated with donepezil.
    Matsuda O
    Int Psychogeriatr; 2007 Apr; 19(2):241-52. PubMed ID: 17005066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of memantine on sleep architecture and psychiatric symptoms in patients with Alzheimer's disease.
    Ishikawa I; Shinno H; Ando N; Mori T; Nakamura Y
    Acta Neuropsychiatr; 2016 Jun; 28(3):157-64. PubMed ID: 26572055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of neuropsychological and functional outcomes in Alzheimer's disease patients with good or bad response to a cognitive stimulation treatment: a retrospective analysis.
    Martínez-Moreno M; Cerulla N; Chico G; Quintana M; Garolera M
    Int Psychogeriatr; 2016 Nov; 28(11):1821-1833. PubMed ID: 27503001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of a community-based multidomain cognitive intervention program in patients with Alzheimer's disease.
    Kim HJ; Yang Y; Oh JG; Oh S; Choi H; Kim KH; Kim SH
    Geriatr Gerontol Int; 2016 Feb; 16(2):191-9. PubMed ID: 25656505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adding Chinese herbal medicine to conventional therapy brings cognitive benefits to patients with Alzheimer's disease: a retrospective analysis.
    Shi J; Ni J; Lu T; Zhang X; Wei M; Li T; Liu W; Wang Y; Shi Y; Tian J
    BMC Complement Altern Med; 2017 Dec; 17(1):533. PubMed ID: 29237450
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.